Senior Oncology Clinical Development Lead

Exelixis; Alameda (CA); On-site; USD 318,000 - 402,000; Full time

Benefits offered by this job

401k plan with company contributions

Medical, dental & vision coverage

Discretionary annual bonus program

Stock purchase plan

15 vacation days (first year)

17 paid holidays

Up to 10 sick days

Job summary

Exelixis in Alameda, CA seeks a senior physician leader to design and execute early/late-stage oncology clinical trials. You will monitor safety, interact with investigators and KOLs, and ensure robust data interpretation for regulatory submissions.

The ideal candidate has an MD in Oncology, 8+ years post-residency, and extensive experience in biotech/pharma drug development with molecularly targeted or immuno-oncology therapies.

Qualifications

• MD with board certification/eligibility in Oncology; 8+ years post-residency.
• Experience in biotech/pharma drug development, oncology trials.
• Hands-on design, execution and reporting of oncology trials.
• Interaction with key opinion leaders and investigators.

Responsibilities

• Design, prepare and initiate study protocols per plans, regulations and GCP.
• Act as medical monitor for company-sponsored trials.
• Support project teams with therapeutic area information.
• Collaborate with internal safety group on safety data reporting.
• Analyze and interpret trial data; prepare regulatory/publication reports.
• Interact with investigators and key opinion leaders in oncology.
• Ensure consistency of scientific/development strategies for oncology assets.
• Maintain high-level scientific/clinical knowledge in oncology.

Skills

MD in Oncology

Oncology drug development

Clinical trial design

Medical monitoring

Cross-functional collaboration

KOL engagement

Safety data analysis

Regulatory knowledge (GCP/Regulatory)

Education

MD (board cert/eligibility in Oncology)

Equivalent education/experience

Job description

Exelixis in Alameda, CA seeks a senior physician leader to design and execute early/late-stage oncology clinical trials. You will monitor safety, interact with investigators and KOLs, and ensure robust data interpretation for regulatory submissions.

The ideal candidate has an MD in Oncology, 8+ years post-residency, and extensive experience in biotech/pharma drug development with molecularly targeted or immuno-oncology therapies.